Trump Agencies Seek Ideas to Improve Drug Price Transparency

The Trump administration is seeking public input for potential rulemaking on how to improve prescription drug price transparency for consumers.

The request for information issued jointly Thursday by the departments of Labor, Health and Human Services, and Treasury seeks feedback on ways to “effectively implement or amend the disclosure requirements related to prescription drug expenditures” under the “Transparency in Coverage” final rule issued in 2020.

The rule requires group health plans, and insurers that offer group or individual health insurance coverage, to publicly disclose certain information relating to prescription drug expenditures. But in subsequent years, the departments issued guidance that ...